Qube Research & Technologies LTD Catalent, Inc. Transaction History

Qube Research & Technologies LTD

  • $62.3 Billion
  • Q2 2024

A detailed history of Qube Research & Technologies LTD transactions in Catalent, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 27 shares of CTLT stock, worth $1,619. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27
Previous 79,950 99.97%
Holding current value
$1,619
Previous $4.51 Million 99.98%
% of portfolio
0.0%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$53.58 - $57.02 $4.28 Million - $4.56 Million
-79,923 Reduced 99.97%
27 $1,000
Q1 2024

May 14, 2024
BUY
$42.56 - $59.82 $3.25 Million - $4.57 Million
76,326 Added 2106.13%
79,950 $4.51 Million
Q4 2023

Feb 13, 2024
BUY
$32.18 - $46.57 $1,319 - $1,909
41 Added 1.14%
3,624 $162,000
Q3 2023

Nov 13, 2023
BUY
$44.2 - $50.2 $158,368 - $179,866
3,583 New
3,583 $163,000
Q1 2022

May 09, 2022
SELL
$94.19 - $124.49 $6.67 Million - $8.81 Million
-70,783 Closed
0 $0
Q4 2021

Feb 01, 2022
SELL
$119.57 - $139.07 $1.38 Million - $1.6 Million
-11,529 Reduced 14.01%
70,783 $9.06 Million
Q3 2021

Nov 12, 2021
BUY
$109.17 - $142.35 $498,906 - $650,539
4,570 Added 5.88%
82,312 $11 Million
Q2 2021

Aug 13, 2021
BUY
$100.34 - $115.69 $7.2 Million - $8.31 Million
71,798 Added 1207.91%
77,742 $8.41 Million
Q1 2021

May 14, 2021
BUY
$101.51 - $125.27 $603,375 - $744,604
5,944 New
5,944 $626,000
Q4 2020

Feb 16, 2021
SELL
$85.88 - $105.36 $4.63 Million - $5.69 Million
-53,966 Closed
0 $0
Q3 2020

Nov 12, 2020
BUY
$72.74 - $92.5 $3.93 Million - $4.99 Million
53,966 New
53,966 $4.62 Million
Q2 2020

Aug 14, 2020
SELL
$48.02 - $79.04 $229,679 - $378,048
-4,783 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$36.95 - $62.95 $176,731 - $301,089
4,783 New
4,783 $248,000
Q4 2019

Feb 13, 2020
SELL
$47.06 - $56.64 $569,378 - $685,287
-12,099 Closed
0 $0
Q3 2019

Nov 13, 2019
BUY
$47.45 - $58.05 $331,343 - $405,363
6,983 Added 136.49%
12,099 $577,000
Q2 2019

Aug 02, 2019
BUY
$39.26 - $54.21 $200,854 - $277,338
5,116 New
5,116 $277,000
Q4 2018

Feb 14, 2019
SELL
$29.95 - $46.34 $167,540 - $259,225
-5,594 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$40.12 - $45.55 $193,538 - $219,733
4,824 Added 626.49%
5,594 $255,000
Q2 2018

Aug 14, 2018
BUY
$38.72 - $42.52 $29,814 - $32,740
770 New
770 $32,000

Others Institutions Holding CTLT

# of Institutions
489
Shares Held
165M
Call Options Held
364K
Put Options Held
837K
View Full List

About Catalent, Inc.

CTLT Quotes by TradingView
  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.8B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email